The Effect of Beetroot Powder on Exercise Performance in Competitive Swimmers
perjantai 19. kesäkuuta 2026 päivittänyt: Aysun Köktürk Bayram, Halic University
Swimming requires high energy in a short time and involves overcoming water resistance. Besides regular training, swimmers use supplements to enhance performance, correct nutrient deficiencies, and speed recovery. The Australian Institute of Sport (AIS) classifies supplements by evidence level, with nitrate in Group A. Nitrate aids vasodilation and muscle performance via conversion to nitric oxide (NO).
About 25% of dietary nitrate converts to nitrite by oral bacteria, then to NO in the stomach-a valuable oxygen-independent pathway. NO improves exercise by enhancing oxygen efficiency, muscle contraction, and affecting type II fibers. Timing, dose, nitrate source, and individual traits influence its effect. Beetroot, rich in nitrate, is practical as juice for storage and consumption.
Beetroot gels and juices raise plasma nitrate 1-3 hours post-consumption, effective during 10-17 minute exercises. Some studies found no improvement in short-distance swimming, but others reported dose-dependent benefits. Meta-analyses recommend 5-14.9 mmol nitrate ≥150 minutes before acute exercise, and 5-9.9 mmol for chronic intake. Highly trained athletes may need ≥6-8 mmol NO₃-.
JECFA and the European Commission set acceptable daily intake (ADI) at 0-3.7 mg/kg body weight nitrate ion, safe for all ages.
No long-term, controlled studies exist on beetroot powder's effect in swimmers. To address this, a randomized, placebo-controlled, triple-blind crossover study was designed to evaluate beetroot powder supplementation's impact on competitive swimmers' performance, potentially contributing valuable knowledge.
Tutkimuksen yleiskatsaus
Tila
Valmis
Interventio / Hoito
Yksityiskohtainen kuvaus
- Study Design and Participants: This study employed a randomized, double-blind, placebo-controlled crossover design to investigate the effects of beetroot supplementation. Based on a power analysis conducted with a 5% error level and a statistical power of 0.95, a sample size of 36 participants was determined to be sufficient. The study was conducted over a one-year period at the Galatasaray Swimming Club following approval from the institutional ethics committee, and all participants provided written informed consent. Inclusion criteria required voluntary participation with parental consent, an age range of 18-24 years, participation in a structured training program for at least 18 hours per week, no history of chronic disease, no current use of sports or food supplements/medications, and no adherence to a special diet. Conversely, exclusion criteria included irregular training attendance, the presence of chronic diseases, and a failure to cease the use of food supplements one week prior to the study.
- Product Development and Standardization: Three types of beetroot powder were selected from the Turkish market and analyzed by a laboratory accredited under the TURKAK TS EN ISO/IEC 17025:2017 standard, utilizing the HPLC-DAD method in accordance with NMKL No. 165. Based on these analyses, 1.5 g of beetroot powder, corresponding to a 10 mmol nitrate intervention, was used for product development at the Haliç University Nutrition Principles Laboratory. A base mixture of water, gelatin, pectin, starch, and stevia was heated to 85-90°C for homogenization and cooled to 55-60°C. The intervention product contained 1.5 g of beetroot powder, while the placebo product included food coloring to match the visual characteristics of the intervention. Products were prepared 24 hours before each session, stored in opaque, food-safe packaging at 0-4°C, and coded by an independent researcher using a random number generator to ensure triple-blind conditions.
- Experimental Procedure and Controls: Participants were instructed to maintain their habitual dietary intake throughout the study and were provided with a list of nitrate-rich foods to avoid. To prevent interference with oral nitrate-to-nitrite reduction, participants were strictly instructed to abstain from mouthwash, chewing gum, sweets, stimulants, and alcohol on all intervention days. The study consisted of five visits. Visit 1 involved providing study information and obtaining informed consent, while Visit 2 included baseline anthropometric assessments and randomization. Visit 3 involved data collection, including food record retrieval, a standardized warm-up, a 200-m freestyle performance test, and post-test measurements of blood lactate, heart rate, and fatigue. A two-week washout period was implemented between intervention phases to eliminate potential carry-over effects, followed by Visits 4 and 5, where the crossover intervention was conducted by repeating the established testing protocols with the alternative condition.
- Data Collection: Sociodemographic and lifestyle data, including age, sex, education, nutritional habits, and training characteristics, were recorded. Anthropometric measurements included body composition via bioelectrical impedance analysis, height, BMI, and hand grip strength measured by a digital dynamometer. Performance was assessed through a 200-m maximum-effort freestyle swimming test. Physiological assessments included fingertip blood lactate concentration and heart rate (resting, maximum, and average). Finally, subjective fatigue was evaluated using the Perceived Physical and Cognitive Fatigue Scale and the Visual Analog Scale (VAS).
Opintotyyppi
Interventio
Ilmoittautuminen (Todellinen)
21
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.
Opiskelupaikat
-
-
Kartal
-
Istanbul, Kartal, Turkki (Türkiye)
- Kartal Kosuyolu Yuksek Ihtisas EAH
-
-
Osallistumiskriteerit
Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.
Kelpoisuusvaatimukset
Opintokelpoiset iät
- Aikuinen
Hyväksyy terveitä vapaaehtoisia
Joo
Kuvaus
Inclusion Criteria:
- Voluntary participation with parental consent
- Age range: 18-24 years
- Participation in a training program for at least 18 hours per week
- No history of chronic disease
- Not currently using any sports supplements, food supplements, or medications
- Not following a special diet
Exclusion Criteria:
- Irregular training participation
- Presence of chronic diseases
- Failure to cease the use of food supplements one week prior to the study
Opintosuunnitelma
Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Tukevaa hoitoa
- Jako: Satunnaistettu
- Inventiomalli: Crossover-tehtävä
- Naamiointi: Nelinkertaistaa
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Kokeellinen: Beetroot then Placebo
Participants in this arm will first receive 1,5 grams of beetroot powder contain jelly candy daily for 3 consecutive days.
After a 14-day washout period, they will receive placebo jelly candy daily for 3 consecutive days.
|
1.5 g of beetroot powder (equivalent to 10 mmol nitrate) administered as a jelly candy.
Color-matched, nitrate-free jelly candy.
|
|
Placebo Comparator: Placebo then Beetroot
Participants in this arm will first receive placebo jelly candy daily for 3 consecutive days.
After a 14-day washout period, they will receive 1,5 grams of beetroot powder contain jelly candy daily for 3 consecutive days.
|
1.5 g of beetroot powder (equivalent to 10 mmol nitrate) administered as a jelly candy.
Color-matched, nitrate-free jelly candy.
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Change in 200-meter swim performance time
Aikaikkuna: On the 3rd day of each 3-day intervention period (after beetroot or placebo supplementation).
|
The duration (in seconds) required for the participant to complete a 200-meter freestyle swim, measured using a Seiko stopwatch.
|
On the 3rd day of each 3-day intervention period (after beetroot or placebo supplementation).
|
|
Blood lactate concentration
Aikaikkuna: Immediately post-exercise on the 3rd day of each 3-day intervention period (after beetroot or placebo supplementation).
|
Blood lactate levels (mmol/L) measured from capillary blood samples collected 3 minutes after completion of 200-meter swim test.
|
Immediately post-exercise on the 3rd day of each 3-day intervention period (after beetroot or placebo supplementation).
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Visual Analog Scale (VAS) for Perceived Fatigue
Aikaikkuna: On the 3rd day of each 3-day intervention period (after beetroot or placebo supplementation).
|
Participant's self-reported fatigue level assessed using a 10-cm visual analog scale, ranging from 0 (no fatigue) to 10 (extreme fatigue), completed immediately after the swim test.
|
On the 3rd day of each 3-day intervention period (after beetroot or placebo supplementation).
|
|
Heart Rate Change
Aikaikkuna: On the 3rd day of each 3-day intervention period (after beetroot or placebo supplementation).
|
Maximum heart rate during the 200m swim, heart rate at 1 minute post-performance, and mean heart rate during the test, recorded using a Polar sports watch with an integrated wrist-based optical heart rate monitor.
|
On the 3rd day of each 3-day intervention period (after beetroot or placebo supplementation).
|
|
Change in Perceived Physical and Cognitive Fatigue Scale (AFBYÖ) Scores
Aikaikkuna: On the 3rd day of each 3-day intervention period (after beetroot or placebo supplementation).
|
The 19-item Perceived Physical and Cognitive Fatigue Scale (PPCFS) is a 5-point Likert-type instrument used to assess athletes' perceived fatigue levels after each training session.
The scale consists of two subscales: the Perceived Physical Fatigue (PPF) subscale, which includes the first 8 items with a total score range of 8 to 40, and the Perceived Cognitive Fatigue (PCF) subscale, which includes the remaining 11 items with a total score range of 11 to 55.
The total score of the scale ranges from 19 to 95, where higher scores in either the subscales or the total score indicate increased levels of physical and cognitive fatigue, respectively.
|
On the 3rd day of each 3-day intervention period (after beetroot or placebo supplementation).
|
|
Daily Energy and Nutrient Intake
Aikaikkuna: Collected during the 24-hour period prior to the 3rd day of each 3-day intervention period (both beetroot or placebo supplementation).
|
Dietary intake was monitored through 24-hour dietary records kept by participants for 24 hours prior to each measurement day.
Ingredient quantities for composite dishes were calculated using the "Standard Food Recipes" manual.
Subsequently, total daily energy and nutrient intakes were analyzed and quantified using the Nutrition Information System (BeBİS) software.
|
Collected during the 24-hour period prior to the 3rd day of each 3-day intervention period (both beetroot or placebo supplementation).
|
Yhteistyökumppanit ja tutkijat
Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.
Sponsori
Julkaisuja ja hyödyllisiä linkkejä
Tutkimusta koskevien tietojen syöttämisestä vastaava henkilö toimittaa nämä julkaisut vapaaehtoisesti. Nämä voivat koskea mitä tahansa tutkimukseen liittyvää.
Hyödyllisiä linkkejä
Opintojen ennätyspäivät
Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan julkisella verkkosivustolla.
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Maanantai 22. joulukuuta 2025
Ensisijainen valmistuminen (Todellinen)
Perjantai 22. toukokuuta 2026
Opintojen valmistuminen (Todellinen)
Maanantai 1. kesäkuuta 2026
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Tiistai 16. kesäkuuta 2026
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Perjantai 19. kesäkuuta 2026
Ensimmäinen Lähetetty (Todellinen)
Tiistai 23. kesäkuuta 2026
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Tiistai 23. kesäkuuta 2026
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Perjantai 19. kesäkuuta 2026
Viimeksi vahvistettu
Torstai 1. toukokuuta 2025
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Muut tutkimustunnusnumerot
- 2025-08/318
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
EI
IPD-suunnitelman kuvaus
Individual participant data (IPD) will not be shared due to concerns regarding participant confidentiality and the small sample size, which may increase the risk of re-identification.
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Ei
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Ei
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .